Table 1.
Area of study | Author | Journal | Publication year | Study design |
Year of study |
Type | Total fistula | Total OF |
---|---|---|---|---|---|---|---|---|
South Australia | Rieger et al. [20] | ANZJOG | 2004 | Retrospecti | 1999–2001 | RVpur | 89 | 89 (100%) |
Saudi Arabia | Rahman et al. [10] | JOG | 2003 | Retrospect | 1986–2001 | RVpur | 52 | 52 (100%) |
Niger | Nafiou et al. [21] | Int J G O | 2007 | Retrospect | 2003–2005 | VVpur | 104 | 104 (100%) |
Niger | Meyer et al. [22] | Am J O G | 2007 | Retrospect | 2005–2006 | VVpur | 58 | 58 (100%) |
Nigeria | Ijaiya and Aboyeji [23] | WAJM | 2004 | Retrospect | 1989–1998 | VVpur | 34 | 34 (100%) |
Nigeria | Melah et. al [4] | J OG | 2007 | Survey | 2001–2003 | VVc | 80 | 75/80 (93.7) |
Pakistan | Ahmad et. al [24] | Int J G O | 2005 | Retrospect | 1978–2003 | VVc | 1086 | 1,086 (100%) |
Nigeria | Waaldijk [5, 25] | Am J O G | 2004 | Retrospect | 1992–2001 | VVc | 1716 | 1,716 (100%) |
Nigeria | Wall et al. [26] | Am J O G | 2004 | Retrospect | 1992–1999 | VVc | 932 | 899/932 (95.5) |
Mali | Qi Li Ya et al. [27] | Med Afr N | 2000 | Retrospect | 1998–1999 | VVc | 34 | 27/34 (79.4) |
Nigeria | Hilton and Ward [28] | IUGJPFLD | 1998 | Retrospect | 1989–1995 | VVc | 2389 | (2,202/2,389) 92% |
Niger | Arrowsmith [29] | J Urol | 1994 | Retrospect | 1990–1993 | VVc | 98 | 93/98 (94.9) |
Senegal | Gueye et al. [30] | Med Afr N | 1992 | Retrospect | 1986–1992 | VVc | 123 | 118/123 (95.9) |
Burki, Tchad; Gabon | Falandry [31] | Press Med | 1992 | Retrospect | 1979–1990 | VVc | 230 | 213/230 (93%) |
Zambia | Holme et al. [7] | Br J O G | 2007 | Retrospect | 2003–2005 | V/R | 259 | 259 (100%) |
Malawi | Rijken and Chilopora [32] | Int J G O | 2007 | Retrospect | 1997–2005 | V/R | 407 | 379/407 (93.1) |
Pakistan | Jokhio and Kelly [33] | Int J G O | 2006 | Retrospect | 1999–2005 | V/R | 116 | 116 (100%) |
Ethiop | Gessessew and Mesfin [8] | Eth M J | 2003 | Retrospect | 1993–2001 | V/R | 193 | 184/193 (95.3) |
Niger | Harouna et al. [9] | Med Afr N | 2001 | Survey | NP | V/R | 52 | 52 (100.0%) |
IUGJPFLD Int Urogynecol J Pelvic Floor Dysfunct, Retrospect retrospective case series study, RVpur Pur rectovaginal fistulas, VVpur pure vesicovaginal fistula, VVc vesicovaginal fistula including associated rectovaginal fistula in the same patient, V/R studies including pure vesicovaginal cases, pure rectovaginal cases and associated cases, OF obstetric fistula